Picture of Orion Oyj logo

ORNBV Orion Oyj Share Price

0.000.00%
fi flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Momentum

Relative Strength (%)
1m+4.75%
3m+9.15%
6m+22.36%
1yr+49.59%
Volume Change (%)
10d/3m+18.13%
Price vs... (%)
52w High-5.89%
50d MA+2.05%
200d MA+13.78%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)19.42
PEG Ratio (f)1.74
EPS Growth (f)12.6%
Dividend Yield (f)3.29%
Valuation (ttm)IndustryMarket
Price to Book Value7.16
Price to Tang. Book8.58
Price to Free Cashflow42.99
Price to Sales4.81
EV to EBITDA15.84

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital30.98%
Return on Equity39.18%
Operating Margin27.6%

Financial Summary

Year End 31st DecUnit202020212022202320242025E2026ECAGR / Avg
Total Revenue€m1,078.11,0411,340.61,189.71,542.41,624.891,982.097.97%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+10.22-13.41+82.85-46.46+92.25-9.33+64.53n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202531st Dec 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of Orion Oyj EPS forecast chart

Profile Summary

Orion Oyj is a Finland-based company engaged in the development, manufacture and marketing of pharmaceuticals and diagnostic tests. The Company operates, along with its subsidiaries, in two business segments: the Pharmaceuticals business segment develops, manufactures and markets pharmaceuticals and active pharmaceutical ingredients, and the Diagnostics business segment develops, manufactures and markets diagnostic tests. The Company’s business comprises two main divisions: Proprietary Products and Specialty Products. Its Proprietary Products consist of patented prescription products in three therapy areas: central nervous system diseases, oncology and critical care, and Easyhaler pulmonary drugs. The Company’s Specialty Products, which include the provision of generic prescription drugs and self-care products for basic healthcare. In addition the Company also produces veterinary medicines for pets and production animals.

Directors

Last Annual
December 31st, 2024
Last Interim
March 31st, 2025
Incorporated
July 1st, 2006
Public Since
July 3rd, 2006
No. of Shareholders
90,222
No. of Employees
3,943
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
fi flag iconOMX Nordic Exchange - Helsinki
Shares in Issue
140,693,334

ORNBV Share Price Performance

Upcoming Events for ORNBV

Orion Oyj Capital Markets Day

Half Year 2025 Orion Oyj Earnings Release

Dividend For ORNBV.HE - 0.8200 EUR

Dividend For ORNAV.HE - 0.8200 EUR

Similar to ORNBV

Picture of Biohit Oyj logo

Biohit Oyj

fi flag iconOMX Nordic Exchange - Helsinki

Picture of Oriola Oyj logo

Oriola Oyj

fi flag iconOMX Nordic Exchange - Helsinki

FAQ